PlushCare is a complete primary care platform that accepts insurance, while Shed is a dedicated GLP-1 weight loss platform with a 10% guarantee. If insurance coverage matters, this comparison is critical.
Platform Overview
PlushCare is a primary care telehealth platform that has expanded into GLP-1 weight loss treatment, offering programs at $99-$399 per month and accepting insurance for many services. Unlike GLP-1 specialists, PlushCare operates as a complete primary care provider that can address weight loss alongside annual physicals, chronic disease management, mental health referrals, and other primary care needs. The platform's insurance acceptance is a significant differentiator for patients who want to apply coverage toward their weight loss treatment costs. PlushCare's network of board-certified physicians provides standard-of-care prescribing for GLP-1 medications. The FDA's GLP-1 approval framework applies to PlushCare's prescribing protocols as with all licensed providers.
Shed is a GLP-1 weight loss specialist that does not accept insurance but delivers a more specialized weight loss program at $199-$499 per month, with a 10% body weight loss guarantee and dedicated weight loss coaching. Shed's specialist model allows deeper weight-loss-specific program design than a primary care generalist platform like PlushCare can provide, and the outcome guarantee is a meaningful differentiator for patients not covered by insurance. The
CDC's weight management research supports the specialist model Shed employs, particularly for patients whose primary health goal is meaningful, sustained weight reduction.
Pricing Comparison
PlushCare's $99-$399 pricing range - particularly at the lower end when insurance is applied - can make it significantly cheaper than Shed for eligible patients. Insurance coverage for weight loss treatment varies by plan, but patients with employer-sponsored coverage that includes GLP-1 treatment or telehealth visits may find PlushCare dramatically reduces their out-of-pocket costs. For patients without insurance coverage, PlushCare's pricing is competitive but the specialist coaching and outcome guarantee at Shed may represent better value.
NIH research on access barriers identifies cost as the single largest obstacle to GLP-1 treatment initiation.
Shed's $199-$499 per month pricing is higher than PlushCare's uninsured floor, but the 10% weight loss guarantee and dedicated coaching represent value that PlushCare's primary care model does not include. For patients paying out of pocket, the guarantee changes the financial risk calculation: Shed commits to a specific outcome, while PlushCare provides GLP-1 access within a primary care framework without a corresponding weight loss commitment. Patients who cannot access insurance coverage and are paying the full cost should weigh Shed's guarantee and coaching against PlushCare's lower pricing.
Medication Options and Quality
PlushCare's primary care model means it can prescribe both branded GLP-1 medications (Wegovy, Ozempic, Zepbound) and compounded versions, potentially including insurance-covered branded options that are unavailable through most telehealth-only platforms. Access to branded medications through insurance channels is a significant advantage for covered patients, as branded GLP-1 drugs undergo more rigorous manufacturing standards than compounded alternatives. PlushCare physicians also manage the prior authorization process for insurance coverage of branded medications, which most GLP-1 telehealth specialists are not equipped to handle.
NEJM semaglutide trial data applies equally to branded and properly compounded formulations.
Shed provides semaglutide and tirzepatide through licensed compounding pharmacies, with medication management integrated into the weight loss coaching program. The platform does not accept insurance and does not prescribe branded GLP-1 medications, focusing instead on high-quality compounded options at the weight loss program price point. Shed's medication management is effective and appropriate for most patients, and tirzepatide's 20%+ average weight loss in
NEJM trials demonstrates the clinical power of the medications it prescribes.
Medical Team and Support
PlushCare's network of board-certified physicians provides primary care-level support that extends well beyond weight loss management. Patients can address weight loss alongside other health conditions, get referrals, order labs, and receive complete primary care through the same platform. This breadth of clinical support is valuable for patients whose weight is linked to other manageable conditions. However, the weight-loss-specific coaching depth at PlushCare is limited compared to specialist platforms - the primary care model prioritizes breadth over weight-loss-specific depth. JAMA research shows that weight-loss-specific behavioral support produces better adherence than general primary care follow-up.
Shed's medical support combines licensed physician and nurse practitioner clinical oversight with dedicated weight loss coaches who are the primary ongoing contact for program patients. This coaching model provides structured behavioral support that primary care providers are not designed or resourced to deliver. The
American Association of Clinical Endocrinology explicitly recommends combined pharmacological and behavioral treatment as the standard for obesity management - a model Shed has built into every patient's program through its coaching infrastructure.
Weight Loss Approach and Programs
PlushCare's weight loss approach follows primary care best practices, which include GLP-1 prescribing for appropriate patients, lifestyle counseling, and referral to additional support resources as needed. The primary care model is complete but not specialized - weight loss is one of many conditions PlushCare manages, and the program depth is calibrated for a general patient population rather than weight-loss-intensive program design. Patients who want seamless integration of their weight loss treatment into broader primary care management will find PlushCare's model the most convenient option.
Research from Obesity journal shows specialist program support outperforms generalist approaches for sustained outcomes.
Shed's weight loss approach is built entirely around its 10% body weight guarantee, with every clinical and coaching element calibrated to achieve that committed outcome. The program is structured, goal-directed, and specifically designed for patients whose primary health objective is meaningful weight reduction through GLP-1 treatment. The guarantee creates strong outcome incentives for both the platform and the patient, resulting in a more intensive and accountable program experience than primary care weight loss management typically provides.
User Experience and Satisfaction
PlushCare users appreciate the convenience of complete primary care through a telehealth interface, and those with insurance coverage particularly value the ability to apply their benefits to weight loss treatment. The platform's user experience is polished and its physician network is large, meaning appointment availability is generally good. Patients managing multiple health conditions find the consolidated primary care model extremely convenient. Some patients note that the weight-loss-specific coaching and program management features are less developed than specialist platforms, which is an expected limitation of the primary care model.
Shed users describe a highly focused, accountability-driven experience shaped by the weight loss guarantee and proactive coaching model. The platform's weight-loss-specific design means progress tracking, coaching interactions, and program milestones are all purpose-built for the treatment goal. The guarantee creates a shared accountability dynamic that patients describe as motivating and trust-building. For patients who are paying out of pocket and want to maximize their return on investment, Shed's guarantee and coaching model deliver a program experience that PlushCare's primary care approach does not replicate.
NIH adherence research supports this structured approach.
How We Tested PlushCare vs Shed
Our Comparison Methodology
This comparison is based on complete analysis supplemented by peer-reviewed research on weight loss treatment.
Clinical Evidence: Weight loss treatment recommendations reference FDA-approved GLP-1 medication information (FDA Wegovy Label), obesity treatment guidelines from the American Association of Clinical Endocrinology, and clinical efficacy data from The New England Journal of Medicine.
Research Foundation: We analyzed peer-reviewed studies including GLP-1 medication efficacy from Obesity and behavioral support impact from JAMA.
Pricing Analysis: All pricing reflects published rates as of March 2026, verified through official platform websites.
Service Verification: Platform capabilities, provider credentials, and service quality were evaluated through detailed review of service offerings.
We maintain independence from both platforms and receive no compensation. Our goal is to provide evidence-based comparison to help you make informed weight loss treatment decisions.
Final Verdict: PlushCare vs Shed
Choose PlushCare if: You have insurance coverage that can be applied to GLP-1 treatment, want access to branded Wegovy or Zepbound through insurance prior authorization, or need complete primary care management alongside your weight loss treatment. PlushCare's insurance acceptance and primary care breadth make it the stronger choice for insured patients.
Choose Shed if: You are paying out of pocket for weight loss treatment and want the strongest specialist program with a guaranteed outcome. Shed's 10% weight loss guarantee and dedicated coaching model deliver weight-loss-specific value and accountability that PlushCare's primary care approach cannot match for direct-pay patients.
Bottom line: PlushCare and Shed serve complementary patient profiles. Insured patients should explore PlushCare's coverage options first, as insurance can dramatically reduce the net cost advantage. Uninsured patients paying out of pocket will generally find Shed's specialist program with outcome guarantee to be the stronger investment for achieving and sustaining meaningful weight loss results.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
